Skip to main content
Cellular and Molecular Life Sciences: CMLS logoLink to Cellular and Molecular Life Sciences: CMLS
. 2006 Jun 24;63(15):1752. doi: 10.1007/s00018-005-5463-y

Phytanic acid: production from phytol, its breakdown and role in human disease

D M van den Brink 1,2, R J A Wanders 1,
PMCID: PMC11136310  PMID: 16799769

Abstract.

Phytanic acid is a branched-chain fatty acid that accumulates in a variety of metabolic disorders. High levels of phytanic acid found in patients can exceed the millimolar range and lead to severe symptoms. Degradation of phytanic acid takes place by α-oxidation inside the peroxisome. A deficiency of its breakdown, leading to elevated levels, can result from either a general peroxisomal dysfunction or from a defect in one of the enzymes involved in α-oxidation. Research on Refsum disease, belonging to the latter group of disorders and characterized by a deficiency of the first enzyme of α-oxidation, has extended our knowledge of phytanic acid metabolism and pathology of the disease greatly over the past few decades. This review will centre on this research on phytanic acid: its origin, the mechanism by which its α-oxidation takes place, its role in human disease and the way it is produced from phytol.

Keywords. Phytanic acid, Refsum disease, phytol, α-oxidation, peroxisome biogenesis disorder, rhizomelic chondrodysplasia punctata, peroxisome

Footnotes

Received 4 October 2005; received after revision 24 February 2006; accepted 26 April 2006


Articles from Cellular and Molecular Life Sciences: CMLS are provided here courtesy of Springer

RESOURCES